A61K 38 - Medicinal preparations containing peptides

Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
11/2006
11/02/2006	EP1715892A2 Methods and compositions for modulating angiogenesis
11/02/2006	EP1715890A1 Ctgf as target for the therapy of diabetic nephropathy
11/02/2006	EP1715888A2 Treatment of abnormalities of the first metatarsophalangeal joint of the foot
11/02/2006	EP1715887A1 N-terminally monopegylated human growth hormone conjugates, process for their preparation, and methods of use thereof
11/02/2006	EP1715886A2 Hydrocephalus treatment
11/02/2006	EP1715885A2 Compositions and methods for enhanced mucosal delivery of y2 receptor-binding peptides and methods for treating and preventing obesity
11/02/2006	EP1715884A1 Chaperonin 10 modulation of toll-like receptor-inducible cytokine and chemokine secretion
11/02/2006	EP1715883A1 18-membered nitrobenzyl-substituted and aminobenzyl-substituted cyclohexadepsipeptides for controlling endoparasites, and method for the production thereof
11/02/2006	EP1715882A2 Smac peptidomimetics and the uses thereof
11/02/2006	EP1715881A1 Cysteine rich peptides for improving thiol homeostasis
11/02/2006	EP1715880A2 AN EFFICIENT METHOD TO SYNTHESIZE BENZYL GROUP-PROTECTED ALPHA-PENTAGALLOYLGLUCOSE (&Agr;-PGG) AND ITS ANALOGUES
11/02/2006	EP1715875A2 Systems and methods related to degradation of uremic toxins
11/02/2006	EP1644410A4 Sushi peptide multimer
11/02/2006	EP1554237A4 Methods for synthesis of acyloxyalkyl derivatives of gaba analogs
11/02/2006	EP1517682B1 Pharmaceutical formulation comprising non-peptide renin inhibitor and surfactant
11/02/2006	EP1474172B1 Pharmaceutical compositions for hepatitis c viral protease inhibitors
11/02/2006	EP1341809B1 Glycoprotein peptide of the human herpesvirus-7 for use in particular in an elisa serologic test
11/02/2006	EP1337266A4 Mineralized collagen-polysaccharide matrix for bone and cartilage repair
11/02/2006	EP1337243B1 Delayed-release pharmaceutical formulations containing proinsulin c-peptide
11/02/2006	EP1296636B1 USE OF EXOGENOUS LACTIC BACTERIA STRAIN AGAINST i ACTINOMYCES NAESLUNDII /i RELATED DISEASES
11/02/2006	EP1278525B1 Pyrophosphates for enhancing cellular function through protection of muscarinic receptors
11/02/2006	EP1276760B1 Polyamide nucleic acid derivatives, agents and methods for producing them
11/02/2006	EP1202976B1 Pyrazinones, compositions containing such compounds
11/02/2006	EP1144005B1 Treatment of papillomavirus infections
11/02/2006	EP1107768B1 STABLE HYPOXIA INDUCIBLE FACTOR-1 alpha AND METHOD OF USE
11/02/2006	EP1102589B1 Topical compositions comprising an opioid analgesic and an nmda antagonist
11/02/2006	EP1009417B1 Dietary supplements containing natural ingredients
11/02/2006	EP1006785B1 Antimicrobial proteins
11/02/2006	EP0950416B1 Use of TCF-II for the treatment of cancer related body weight loss, anaemia and TNF elevation
11/02/2006	EP0854722B1 Proteins involved in targeting of peptidyl transfer center, and corresponding therapeutic agents and methods
11/02/2006	EP0769961B1 Use of bacterial enzymes e.g. heparinases, chondroitinases for modulating wound healing processes
11/02/2006	EP0719331B1 Eotaxin = eosinophil chemotactic cytokine
11/02/2006	DE112004002364T5 Berechnung von Vertrauensniveaus zur Peptid- und Proteinidentifikation Calculation of confidence levels for peptide and protein identification
11/02/2006	CA2650556A1 Insulins combinations
11/02/2006	CA2609656A1 Compositions and methods for promoting hemostasis and other physiological activities
11/02/2006	CA2606420A1 Erythrocytes containing arginine deiminase
11/02/2006	CA2606343A1 A closed container comprising an activated factor vii polypeptide, processes for the preparation of the same, and a kit and a method for use of the kit
11/02/2006	CA2606228A1 Methods and compositions for using alveolar macrophage phospholipase a2
11/02/2006	CA2606227A1 Compounds and methods for modulating cadherin-mediated processes
11/02/2006	CA2606030A1 Carrier for targeting nerve cells
11/02/2006	CA2605931A1 Diagnostic and therapeutic agents
11/02/2006	CA2605928A1 N-acetylcysteine amide (nac amide) for treatment of oxidative stress associated with infertility
11/02/2006	CA2605783A1 Matrix metalloproteinase inhibitors of tgf .beta.-induced subcapsular cataract formation
11/02/2006	CA2605723A1 Antibodies to myostatin
11/02/2006	CA2605651A1 Compositions and methods for treating or preventing overweight or obesity with zinc-charged protein fragments
11/02/2006	CA2605592A1 Rate control during af using cellular intervention to modulate av node
11/02/2006	CA2605000A1 Biodegradable peptide sustained release compositions containing porogens
11/02/2006	CA2604999A1 Toxin peptides with extended blood halflife
11/02/2006	CA2604967A1 Pyrimidine derivatives and their use as p2y12 receptor antagonists
11/02/2006	CA2604856A1 Dermal fillers for biomedical applications in mammals and methods of using the same
11/02/2006	CA2604225A1 Surface-modified microparticles and methods of forming and using the same
11/02/2006	CA2603237A1 Novel nutraceutical compositions
11/02/2006	CA2600506A1 Blood pressure lowering protein hydrolysates
11/01/2006	CN1856708A Human diabetes-mediating proteins
11/01/2006	CN1856572A Use of RNAi inhibiting parp activtiy for the manufacture of a medicament for the treatment of cancer
11/01/2006	CN1856505A Secreted chlamydia polypeptides, polynucleotides coding therefor, therapeutic and diagnostic uses thereof
11/01/2006	CN1856504A Anti-infarction molecules
11/01/2006	CN1856503A Peptide originating in hepatitis c virus
11/01/2006	CN1856502A Macrocyclic peptides active against the hepatitis c virus
11/01/2006	CN1856501A Amidomethyl substituted 1-(carboxyalkyl)-cyclopentylcarbonylamino-benzazepine-N-acetic acid derivatives, process and intermediate products for their preparation and medicaments containing these compou
11/01/2006	CN1856321A Use of calcitonin in osteoarthritis
11/01/2006	CN1856320A Novel use of antisecretory factor
11/01/2006	CN1856319A Agent for promoting osteogenesis and/or inhibiting bone resorption
11/01/2006	CN1856313A Therapeutic compounds
11/01/2006	CN1854300A Recombinant plasmid containing PON gene and its use
11/01/2006	CN1854151A Dopamine transfer protein peptide inhibitor and its use
11/01/2006	CN1853732A Matrix metalloproteinase inhibitors as target component in diagnose agent
11/01/2006	CN1853730A Modified cytokines for use in cancer therapy
11/01/2006	CN1853725A Methods for pulmonary delivery of interleukin-2
11/01/2006	CN1853720A Chymotrypsin oral-cavity ulcer membrane
11/01/2006	CN1853719A Pearl-layer hornshell hydrolytic protein drip balls and preparation thereof
11/01/2006	CN1853718A Positioning composition for oral liquid and its preparation
11/01/2006	CN1853717A Cyclosporine microball preparation for treating endophthalmitis
11/01/2006	CN1853716A Nutritive supplementary composition
11/01/2006	CN1853613A Crease-proofing biological preparation, its production and use
11/01/2006	CN1853609A Skin-care effectiveness applied by acid fiber mother cell growth factor (FGF-1)
11/01/2006	CN1282748C Method for preparing leukocyte interferon of pig
11/01/2006	CN1282484C Lipid reducing and regulating agent
11/01/2006	CN1282483C Slow-releasing oxytocic for artificial inducting maturation and ovulation and ejaculation rockfish and use
11/01/2006	CN1282452C Use of aminoadamantane compound as immunoregulators
10/2006
10/31/2006	US7130746 Computer systems and computer programs for determining protein activity levels using gene expression profiles
10/31/2006	US7129374 Catalytic antioxidants and methods of use
10/31/2006	US7129337 Hepatitis C virus (HCV) polynucleic acid of given nucleotide sequence unique to at least one of the new HCV subtypes 7,9,10 OR 11, OR TO SUBTYPES 1D, 1E, 1F, 1G, 2E, 2F, 2G, 2H, 2I, 2K, 2L,3G,4K OR 4M; producing recombinant polypeptide
10/31/2006	US7129335 For cleaving and sequencing polysaccharides such as glycosaminoglycans, removing polysaccharides from solution, inhibiting anticoagulant activity, inhibiting angiogenesis, treating cancer, inhibiting maternal malarial infection
10/31/2006	US7129334 Polypeptides; from snake venom; wound healing agents
10/31/2006	US7129333 Glycoprotein synthesis
10/31/2006	US7129332 Anti-EGFRvIII scFvs with improved cytotoxicity and yield, immunotoxins based thereon, and methods of use thereof
10/31/2006	US7129331 Phosphorylated polypeptides and uses related thereto
10/31/2006	US7129329 Heme proteins hemAT-Hs and hemAT-Bs and their use in medicine and microsensors
10/31/2006	US7129328 Liver tumor marker sequences
10/31/2006	US7129327 Polypeptide and protein derivatives and process for their preparation
10/31/2006	US7129267 Methods for SHP1 mediated neuroprotection
10/31/2006	US7129261 Cytotoxic agents
10/31/2006	US7129256 Antiparkinsonism drugs
10/31/2006	US7129243 Respiratory system disorders; cardiovascular disorders; antidiabetic agents; antiarthritic agents; antiinflammatory agents; immunosuppressants
10/31/2006	US7129226 Mimetic insect allatostatin analogs for insect control
10/31/2006	US7129215 induce the differentiation of HL-60 promyelocytic leukemia cells in vitro, to potentiate the activity of cytotoxic agents both in vitro and in vivo, and to stimulate colony formation of all three lineages of hematopoietic progenitor cells in normal human peripheral blood
10/31/2006	US7129214 Therapy for drug resistant bacteria
10/31/2006	US7129213 Tripeptides and tripeptide derivatives for the treatment of neurodegenerative diseases
10/31/2006	US7129212 Transformation of plant cell with nucleotide sequences coding bacillus insecticidal protein generating insect resistant plants; biological pest control

1 ... 1190 1191 1192 1193 1194 1195 1196 1197 1198 1199 1200 1201 1202 1203 1204 1205 1206 1207 1208 1209 1210 ... 3163